DOUG vs ABOS
Comparison between Douglas Elliman Inc (DOUG, Company) and Acumen Pharmaceuticals Inc (ABOS, Company).
DOUG is from the Real Estate sector, while ABOS is from the Healthcare sector.
DOUG vs ABOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DOUG vs ABOS - Historical Returns
Returns include dividend reinvestment.
DOUG vs ABOS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | DOUG | ABOS |
|---|---|---|
| 2026 | -25.00% | +17.33% |
| 2025 | +45.40% | +14.05% |
| 2024 | -42.61% | -59.34% |
| 2023 | -23.85% | -27.00% |
| 2022 | -61.06% | -19.76% |
| 2021 | -5.19% | -66.37% |
DOUG vs ABOS Drawdown Comparison
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current DOUG drawdown is -83.98%. The current ABOS drawdown is -88.31%.
| Rank | DOUG | ABOS |
|---|---|---|
| #1 | -90.25% Dec 30, 2021 - Jun 17, 2024 | -95.56% Jul 2, 2021 - Apr 17, 2025 |
Correlation
Correlation between DOUG and ABOS is 0.53 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks